About: COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?” Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”
Creator	Kelly, Siobhan Mansoor, Salman Murphy, Kevin Siddiqui, Nauman Waters, Aine
Source	Medline; PMC
abstract	The novel coronavirus which emerged in Wuhan province of China has taken world by surprise. Since been diagnosed in December 2019, it has been termed a “Pandemic” and there is a growing concern in physicians across the globe. As new evidence is emerging, there are various preventative strategies which are being deployed. Multiple sclerosis patients who are on disease modifying therapies (DMTs) might be at a higher risk of acquiring or a poorer outcome due to their immune status. This review looks at the available evidence in managing this global crisis.
has issue date	2020-05-01(xsd:dateTime)
bibo:doi	10.1186/s41983-020-00177-0
bibo:pmid	32372857
has license	cc-by
sha1sum (hex)	e8ebf18705c7cc3f3f638152078e4edfca039cec
schema:url	https://doi.org/10.1186/s41983-020-00177-0
resource representing a document's title	COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: “what the bleep do we know?”
has PubMed Central identifier	PMC7194245
has PubMed identifier	32372857
schema:publication	Egypt J Neurol Psychiatr Neurosurg
resource representing a document's body	covid:e8ebf18705c7cc3f3f638152078e4edfca039cec#body_text
is schema:about of	named entity 'disease' named entity 'preventative' named entity 'Wuhan' named entity 'emerging' named entity 'therapies' named entity 'patients' named entity 'SURPRISE' named entity 'HIGHER' named entity 'EVIDENCE' named entity 'Pandemic' named entity 'strategies' named entity 'emerged' named entity 'China' named entity 'termed' named entity 'China' named entity 'disease modifying therapies' named entity 'lymphocytes' named entity 'ofatumumab' named entity 'helper T cells' named entity 'COVID' named entity 'receptor' named entity 'sphingosine-1-phosphate receptor' named entity 'receptor' named entity 'α4β1-integrin receptor molecules' named entity 'virus' named entity 'virus' named entity 'Coronavirus' named entity 'helper T cells' named entity 'HSCT' named entity 'interleukin' named entity 'viral entry' named entity 'Interferon beta 1a' named entity 'COVID-19' named entity 'helper T cells' named entity 'COVID' named entity 'T lymphocyte' named entity 'Siponimod' named entity 'interferon beta 1b' named entity 'Association of British Neurologists' named entity 'anti-inflammatory' named entity 'lymphocyte activation' named entity 'regulatory T cells' named entity 'Monoclonal antibody' named entity 'COVID-19' named entity 'inflammatory cytokines' named entity 'multiple sclerosis' named entity 'Betacoronavirus' named entity 'COVID' named entity 'Teriflunomide' named entity 'antigen' named entity 'World Health Organization' named entity '4DDB' named entity 'multiple sclerosis' named entity 'inflammation' named entity 'tumor necrosis factor (TNF)-α' named entity 'high-risk' named entity 'exponential rate' named entity 'COVID19' named entity 'novel-coronavirus' named entity 'arzerra' named entity 'infection' named entity 'Antibody' named entity 'Ofatumumab' named entity 'WHO' named entity 'siponimod' named entity 'global pandemic' named entity 'coronavirus' named entity 'A684' named entity 'Natalizumab' named entity 'SARS' named entity 'mechanism of action' named entity 'CD20' named entity 'World Health Organization' named entity 'neurologist' named entity 'ACE-2' named entity 'infection' named entity 'humoral'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software